Microbix Biosystems Inc (MBX.TO)
0.33
0.00 (0.00%)
CAD |
TSX |
Apr 26, 10:55
Microbix Biosystems Cash from Operations (TTM): 0.9583M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.9583M |
| September 30, 2023 | -1.095M |
| June 30, 2023 | 0.5081M |
| March 31, 2023 | 1.086M |
| December 31, 2022 | 3.035M |
| September 30, 2022 | 3.465M |
| June 30, 2022 | 4.940M |
| March 31, 2022 | 1.548M |
| December 31, 2021 | 1.636M |
| September 30, 2021 | 2.107M |
| June 30, 2021 | 0.269M |
| March 31, 2021 | 1.717M |
| December 31, 2020 | -0.0424M |
| September 30, 2020 | 0.0086M |
| June 30, 2020 | 0.7992M |
| March 31, 2020 | -0.1673M |
| December 31, 2019 | 0.2534M |
| September 30, 2019 | 0.0444M |
| June 30, 2019 | -0.1804M |
| March 31, 2019 | 0.1036M |
| December 31, 2018 | 0.9258M |
| September 30, 2018 | -0.537M |
| June 30, 2018 | -1.335M |
| March 31, 2018 | -1.125M |
| December 31, 2017 | -1.447M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.297M |
| June 30, 2017 | 1.182M |
| March 31, 2017 | 1.392M |
| December 31, 2016 | 1.254M |
| September 30, 2016 | 0.9133M |
| June 30, 2016 | 0.561M |
| March 31, 2016 | 0.0309M |
| December 31, 2015 | 0.3685M |
| September 30, 2015 | 0.5954M |
| June 30, 2015 | -0.4686M |
| March 31, 2015 | -0.2271M |
| December 31, 2014 | -0.8842M |
| September 30, 2014 | -1.171M |
| June 30, 2014 | 0.6593M |
| March 31, 2014 | 0.5072M |
| December 31, 2013 | 0.4057M |
| September 30, 2013 | 0.4284M |
| June 30, 2013 | -1.19M |
| March 31, 2013 | -1.520M |
| December 31, 2012 | -1.707M |
| September 30, 2012 | -1.751M |
| June 30, 2012 | -1.168M |
| March 31, 2012 | -1.305M |
| December 31, 2011 | -1.324M |
| September 30, 2011 | -1.299M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.095M
Minimum
Sep 2023
4.940M
Maximum
Jun 2022
1.100M
Average
0.7992M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
| Biocure Technology Inc | -0.4423M |
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Nanosphere Health Sciences Inc | -0.0378M |
| Lobe Sciences Ltd | -2.279M |